Seaport Res Ptn Has Negative Outlook of Curaleaf Q3 Earnings

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) – Seaport Res Ptn cut their Q3 2025 earnings per share estimates for shares of Curaleaf in a report issued on Monday, August 11th. Seaport Res Ptn analyst S. Randhawa now anticipates that the company will post earnings per share of ($0.08) for the quarter, down from their previous forecast of ($0.07). The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share. Seaport Res Ptn also issued estimates for Curaleaf’s Q4 2025 earnings at ($0.08) EPS.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.01. Curaleaf had a negative return on equity of 14.61% and a negative net margin of 18.08%.

Separately, Cormark upgraded Curaleaf from a “hold” rating to a “moderate buy” rating in a report on Friday, August 8th.

Curaleaf Trading Down 4.7%

CURLF opened at $2.94 on Wednesday. The stock’s fifty day moving average is $1.23 and its two-hundred day moving average is $1.10. The company has a market capitalization of $1.97 billion, a P/E ratio of -9.18 and a beta of 0.69. Curaleaf has a 52 week low of $0.68 and a 52 week high of $3.58. The company has a quick ratio of 0.70, a current ratio of 1.47 and a debt-to-equity ratio of 1.00.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.